8月12日港股创新药50ETF（513780）份额增加5650.00万份，最新份额12.40亿份，最新规模22.20亿元

Core Insights - The Hong Kong Innovative Drug 50 ETF (513780) experienced a decline of 0.66% on August 12, with a trading volume of 470 million yuan [1] - The fund's shares increased by 56.5 million, bringing the total shares to 1.24 billion, with a total increase of 542 million shares over the past 20 trading days [1] - The latest net asset value of the fund is calculated at 2.22 billion yuan [1] - The fund's performance benchmark is the CSI Hong Kong Stock Connect Innovative Drug Index return rate, adjusted for valuation exchange rates [1] - Managed by Invesco Great Wall Fund Management Co., the fund has achieved a return of 79.05% since its inception on October 16, 2024, and a return of 16.02% over the past month [1]